Evidence-based·Updated November 20, 2026·How we grade evidence

Azathioprine

MedicationImmunosuppressant (prescription)

Azathioprine is an older immunosuppressant approved for kidney transplant rejection prevention and rheumatoid arthritis. Its boxed warning is malignancy, and it can cause serious drops in blood counts, especially with low TPMT or NUDT15 activity. The critical interaction is with allopurinol (and febuxostat); live probiotic supplements are rated high.

Taking Azathioprine with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Kidney transplant recipients and adults with active rheumatoid arthritis whose specialist prescribes azathioprine

Common dosing range

Set by your prescriber by body weight: usually 3 to 5 mg/kg daily at the start after kidney transplant and 1 to 3 mg/kg for maintenance, or about 1 mg/kg (50 to 100 mg) daily to start for rheumatoid arthritis, up to 2.5 mg/kg

When to expect effects

Several weeks in rheumatoid arthritis, usually 6 to 8; the label says an adequate trial is at least 12 weeks

Watch out for

Boxed warning: higher risk of cancer, including lymphoma. Can cause severe low blood counts, especially with TPMT or NUDT15 deficiency or with allopurinol; needs regular blood counts

What is it

Azathioprine is a prescription immunosuppressant taken as tablets. It is sold as generic azathioprine, as Imuran (50 mg tablets) and as Azasan (75 mg and 100 mg tablets). The label approves it as an add-on treatment to prevent rejection after a kidney transplant and to reduce the signs and symptoms of active rheumatoid arthritis. For rheumatoid arthritis, the label says aspirin, NSAIDs and low-dose steroids may be continued, but that use with other disease-modifying antirheumatic drugs (DMARDs) has not been studied and cannot be recommended; your prescriber decides what fits your treatment. Doctors also use it off-label for other immune conditions, such as Crohn's disease, which the label says it has not been established for. It needs regular blood tests while you take it.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have had a kidney transplant or have active rheumatoid arthritis and your specialist recommends azathioprine
You can keep the schedule of blood counts the label recommends
Every prescriber and pharmacist knows you take it, especially before any gout medicine is started

Probably skip if…

You have had a hypersensitivity reaction to azathioprine (contraindicated)
You are pregnant and it is for rheumatoid arthritis (contraindicated)
You have rheumatoid arthritis previously treated with alkylating agents such as cyclophosphamide, chlorambucil or melphalan, where the label says cancer risk may be prohibitive
You are known to have two non-working copies of TPMT or NUDT15, where the label says to consider other treatment

Evidence at a glance

rheumatoid arthritis

Limited Evidence
Effect
Moderate to large on joint tenderness, with more side-effect withdrawals
Best fit
Adults with active rheumatoid arthritis for whom a specialist judges other options unsuitable
Time
Measured at 6 months

keeping Crohn's disease in remission (off-label)

Limited Evidence
Effect
Small to moderate; about 11 more people in 100 stayed in remission
Best fit
Adults with Crohn's disease in remission whose gastroenterologist recommends a thiopurine
Time
Measured over 6 to 18 months

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

rheumatoid arthritis

Disease adjunct
Limited Evidence

A Cochrane review pooled 3 older placebo-controlled trials with 81 patients with rheumatoid arthritis. Azathioprine improved tender joint scores at 6 months (standardized mean difference -0.98), but withdrawals because of side effects were higher (odds ratio 4.56). Effects on long-term function and joint damage on x-ray could not be assessed. The reviewers found toxicity higher than with other disease-modifying drugs and no evidence to recommend azathioprine over them.

Effect size
Moderate to large on joint tenderness, with more side-effect withdrawals
Time to effect
Measured at 6 months
Best fit
Adults with active rheumatoid arthritis for whom a specialist judges other options unsuitable
Less likely
People who can take better-tolerated disease-modifying drugs

Bottom line: Azathioprine reduced joint tenderness in a few small, old trials, at the cost of more side effects.

keeping Crohn's disease in remission (off-label)

Disease adjunct
Limited Evidence

This is an off-label use; the label says safety and efficacy in Crohn's disease have not been established. A Cochrane review pooled 6 trials with 489 adults whose Crohn's disease was quiet. Over 6 to 18 months, 73% on azathioprine (1.0 to 2.5 mg/kg a day) stayed in remission versus 62% on placebo (risk ratio 1.19; 9 people treated for one extra person to benefit). GRADE certainty was low. Azathioprine raised the risk of serious adverse events (risk ratio 2.45) and of withdrawal for side effects.

Effect size
Small to moderate; about 11 more people in 100 stayed in remission
Time to effect
Measured over 6 to 18 months
Best fit
Adults with Crohn's disease in remission whose gastroenterologist recommends a thiopurine
Less likely
People with surgically induced remission, who were excluded, and young men, in whom rare fatal hepatosplenic T-cell lymphoma cases were mostly reported

Bottom line: Low-certainty evidence suggests azathioprine helps keep Crohn's disease in remission, an off-label use limited by side effects.

How it works

Azathioprine is converted in the body to 6-mercaptopurine and then to thioguanine nucleotides, which get built into the DNA of dividing immune cells and slow their multiplication. The label calls it a slow-acting drug: in rheumatoid arthritis a response usually takes 6 to 8 weeks, and effects may persist after it is stopped. The body inactivates 6-mercaptopurine mainly through two enzymes, TPMT and xanthine oxidase, and a third enzyme, NUDT15, also limits the active products. People born with low TPMT or NUDT15 activity build up active drug and are at risk of severe, life-threatening drops in blood counts. Allopurinol and febuxostat block xanthine oxidase, which is why combining them with azathioprine is the most important interaction. Because azathioprine suppresses the immune system, live probiotic supplements are also a concern.

How to take it

1. Typical dose
Your prescriber sets the dose by body weight and adjusts it to your blood counts. The label lists: kidney transplant, usually 3 to 5 mg/kg daily at the start, reduced to 1 to 3 mg/kg daily for maintenance; rheumatoid arthritis, about 1.0 mg/kg (50 to 100 mg) daily as one dose or split twice a day, increased if needed after 6 to 8 weeks in steps of 0.5 mg/kg every 4 weeks. Lower doses are used with allopurinol (about one-third to one-quarter of the usual dose), with partial TPMT or NUDT15 deficiency, and in poor kidney function.
2. Higher studied dose
For rheumatoid arthritis the label's maximum is 2.5 mg/kg per day.
3. Timing
Usually once daily; in rheumatoid arthritis it may be split into two doses.
4. With food
The label says stomach upset can often be reduced by taking it in divided doses and/or after meals.
5. Split dosing
Allowed in rheumatoid arthritis (twice daily) and can lessen nausea.
6. How long to try
Long term as decided by your prescriber; in rheumatoid arthritis the label suggests slowly lowering to the lowest effective dose. Do not stop or change the dose on your own.

What to track

Complete blood counts with platelets: the label suggests weekly in the first month, twice monthly in months 2 and 3, then monthly or more often after dose or medicine changes
Fever, sore throat, unusual bruising or bleeding, which can signal low blood counts or infection (report promptly)
Liver tests, as your prescriber schedules them
Severe nausea, vomiting, diarrhea, rash or fever in the first weeks, which can be a hypersensitivity reaction
New skin spots; limit sun and ultraviolet exposure and use a high-protection sunscreen
Any new gout medicine (allopurinol or febuxostat), antibiotic or supplement

Bottom line: Your prescriber sets the dose by weight and blood counts; keep every blood test, and never combine it with a gout medicine without your prescriber's plan.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Low white blood cell count (over 50% after kidney transplant, 28% in rheumatoid arthritis, any degree)Nausea and vomiting, in about 12% of 676 rheumatoid arthritis patientsInfections, much more common after transplant than in rheumatoid arthritisRash, hair loss, fever, joint pain and diarrhea (less common)

Serious risks

  • Boxed warning (malignancy): long-term immunosuppression with azathioprine raises the risk of cancer, including post-transplant lymphoma and hepatosplenic T-cell lymphoma (HSTCL) in people with inflammatory bowel disease. HSTCL cases were very aggressive and fatal, mostly in adolescent and young adult males. Skin cancer risk is also higher, so sun exposure should be limited.

  • Severe low blood counts and bone marrow suppression, which can be delayed. People with TPMT or NUDT15 deficiency are at higher risk of severe, life-threatening myelotoxicity, and deaths from pancytopenia have occurred with absent TPMT activity. About 1 in 300 people of European or African ancestry have little or no TPMT activity; among people of East Asian ancestry, about 2% have two non-working NUDT15 copies.

  • Serious infections, including reactivation of latent infections and progressive multifocal leukoencephalopathy (PML), sometimes fatal.

  • Liver injury, mostly in transplant patients, including rare but life-threatening hepatic veno-occlusive disease; a gastrointestinal hypersensitivity reaction with severe nausea and vomiting in the first weeks; pancreatitis; and DRESS.

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Imuran label (Pregnancy Category D) says azathioprine can cause fetal harm, should not be given in pregnancy without carefully weighing risk against benefit, should be avoided in pregnancy whenever possible, and must not be used for rheumatoid arthritis in pregnant women. Low blood counts and immune problems have been reported in a few infants born to transplant recipients taking it. Women of childbearing age are advised to avoid becoming pregnant, and anyone who could become pregnant should discuss this with their doctor. Breastfeeding: the label says use while nursing is not recommended, because azathioprine or its metabolites pass into breast milk at low levels, and a decision should be made whether to stop nursing or stop the drug, taking into account its importance to the mother.

Interactions

AllopurinolCritical

Allopurinol blocks xanthine oxidase, one of the two main routes that inactivate azathioprine, so azathioprine levels and toxicity rise and can cause dangerous bone marrow suppression. The azathioprine and allopurinol labels say the azathioprine dose must be cut to about one-third to one-quarter of the usual dose, with further reduction or another treatment if TPMT activity is low. The two should be combined only when the prescriber managing azathioprine has planned it, with close blood count checks.

FebuxostatCritical

Febuxostat blocks the same enzyme as allopurinol, xanthine oxidase, and can raise azathioprine to toxic levels. The febuxostat (Uloric) label says it is contraindicated in people being treated with azathioprine, and the azathioprine label says using them together is not recommended. In a label study, febuxostat cut the clearance of mercaptopurine, azathioprine's active form, by about 83%, and an FDA review found 19 cases of serious blood count drops with febuxostat and azathioprine or mercaptopurine, 16 of them hospitalized. Tell every prescriber you take azathioprine before any gout treatment is chosen.

Probiotics (live bacteria or yeast supplements)High

In people whose immune system is suppressed, live probiotic organisms can occasionally get into the blood. In a cluster of 6 children after stem cell transplant, the Lactobacillus found in their blood was genetically related to the probiotic they had taken; the report was not a study of azathioprine, and the authors said studies are needed on probiotic safety in immunocompromised patients. Ask your prescriber before taking any probiotic supplement, and report fever or chills promptly.

RibavirinHigh

The label says ribavirin for hepatitis C, used with azathioprine, has been reported to cause severe pancytopenia, because it blocks an enzyme azathioprine needs and a toxic metabolite builds up. If both are used, blood counts are checked weekly in the first month, then twice monthly, then monthly.

Co-trimoxazole, ACE inhibitors and other drugs that lower blood countsModerate

The label says drugs that affect white cell production, including co-trimoxazole, may cause exaggerated leukopenia, especially after kidney transplant, and ACE inhibitors used for blood pressure have been reported to cause anemia and severe leukopenia with azathioprine. It also notes azathioprine may weaken warfarin. Your prescriber may check blood counts more often.

Documented interactions

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic azathioprine, Imuran (50 mg) or Azasan (75 mg or 100 mg) scored tablets on your own prescription
The tablet strength printed on your label, since strengths differ between brands
A note on your pharmacy record that you take azathioprine, so an allopurinol or febuxostat prescription is flagged
Your schedule for blood counts and liver tests

Be skeptical of…

"Immune-boosting" or "natural immune support" supplements presented as safe with immunosuppressants
Probiotic products marketed as safe for people on immunosuppressants without your prescriber's approval
Gout remedies or "uric acid support" products that do not list every ingredient, since allopurinol-type drugs interact critically
Advice to raise your dose to lower your white count; the label says the dose should not be increased for that

Frequently asked questions

Can I take allopurinol with azathioprine?⌄

Only if the prescriber managing your azathioprine has planned it. This page rates the pair critical: allopurinol blocks an enzyme that clears azathioprine, and the labels say the azathioprine dose must be cut to about one-third to one-quarter of usual, with close blood count checks. For febuxostat, another gout medicine that blocks the same enzyme, the febuxostat label says it is contraindicated with azathioprine and the azathioprine label says the combination is not recommended.

Can I take probiotics with azathioprine?⌄

This page rates live probiotic supplements a high-severity concern for people on immunosuppressants. The evidence is limited: one report describes 6 children after stem cell transplant whose bloodstream Lactobacillus was genetically related to the probiotic they had taken, and it was not a study of azathioprine. Ask your prescriber before taking any probiotic.

Why do I need a TPMT or NUDT15 test?⌄

People born with low activity of these enzymes build up active azathioprine and can develop severe, life-threatening low blood counts on usual doses. The label says to consider testing in people with severe bone marrow suppression, and that the test cannot replace regular blood counts. Ask your doctor whether you have been tested.

How often do I need blood tests on azathioprine?⌄

The label suggests a complete blood count with platelets weekly in the first month, twice monthly in the second and third months, then monthly or more often when doses or other medicines change. Your prescriber may also check liver tests.

How long does azathioprine take to work for rheumatoid arthritis?⌄

The label says a response usually takes 6 to 8 weeks, and an adequate trial is at least 12 weeks. Do not change your dose on your own while waiting; discuss progress with your prescriber.

References by claim

rheumatoid arthritis

Suarez-Almazor et al., 2000 · PubMed (2000) link

keeping Crohn's disease in remission (off-label)

Chande et al., 2015 · PMC (2015) link

Safety

Imuran (azathioprine) prescribing information · DailyMed (FDA label) link

Interaction: Allopurinol

Allopurinol tablets prescribing information · DailyMed (FDA label) link

Interaction: Probiotics (live bacteria or yeast supplements)

Gilliam et al., 2023 · PubMed (2023) link

Interaction: Febuxostat

Uloric (febuxostat) prescribing information · DailyMed (FDA label) link

Logan et al., 2020 · PubMed (2020) link

Track Azathioprine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.